Many drugs fail at late stages of development due to efficacy or toxicity issues. BioReperia’s services enable early identification of such issues, increasing the speed of pre-clinical development and success-rate of other candidates.
BioReperia
Bioreperia is a Swedish company that increases the success rate in clinical trials using zebrafish models.
